Literature DB >> 9279361

The isolation of a DNA synthesome from human leukemia cells.

S Lin1, R J Hickey, L H Malkas.   

Abstract

In this report we describe, for the first time, the purification and characterization of a replication-competent multiprotein form of DNA polymerase (designated the DNA synthesome) from the human leukemia cell line (HL-60) using a series of centrifugation, ion-exchange chromatography and velocity sedimentation steps. The proteins and enzymatic activities thus far identified to co-purify with the leukemia cell DNA synthesome include the DNA polymerases alpha and delta, DNA primase, proliferating cell nuclear antigen (PCNA), replication factor C (RF-C), replication protein A (RP-A), and DNA topoisomerases I and II. We have demonstrated that the DNA synthesome is fully competent to replicate simian virus 40 (SV40) replication origin containing DNA in vitro in the presence of the viral large T-antigen. This result implies that all of the cellular activities required for large T-antigen-dependent in vitro SV40 DNA synthesis are present in the isolated human leukemia cell DNA synthesome. Since SV40 is extensively dependent on the host cell's DNA synthetic machinery for its own DNA replication, our results indicate that the isolated leukemia cell DNA synthesome may play a role not only in viral DNA synthesis but also in human leukemia cell DNA replication. We recently proposed a model to represent the DNA synthesome that was isolated from HeLa and murine cells. Our data indicate that the organization of the DNA synthesome from HL-60 cells also fits this proposed model. The purified DNA synthesome will not only allow the further study of the molecular mechanisms required to carry out human leukemia cell DNA replication, but may also provide a tool for eventually dissecting some of the regulatory controls of the cell's DNA synthetic machinery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279361     DOI: 10.1016/s0145-2126(96)00103-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins.

Authors:  Isabelle Frouin; Alessandra Montecucco; Giuseppe Biamonti; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

2.  In vivo association of Ku with mammalian origins of DNA replication.

Authors:  O Novac; D Matheos; F D Araujo; G B Price; M Zannis-Hadjopoulos
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

3.  OBA/Ku86: DNA binding specificity and involvement in mammalian DNA replication.

Authors:  M T Ruiz; D Matheos; G B Price; M Zannis-Hadjopoulos
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

4.  Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome.

Authors:  Heqiao Dai; Jianying Liu; Linda H Malkas; Jennifer Catalano; Srilakshmi Alagharu; Robert J Hickey
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-23       Impact factor: 4.219

5.  Characterization of RNA primers synthesized by the human breast cancer cell DNA synthesome.

Authors:  Heqiao Dai; Jianying Liu; Linda H Malkas; Robert J Hickey
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

6.  Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.

Authors:  Shanna J Smith; Robert J Hickey; Linda H Malkas
Journal:  Cancer Biol Ther       Date:  2016-02-18       Impact factor: 4.742

7.  Effect of novel benzoylphenylurea derivatives on DNA polymerase alpha activity using the synthesome-based in vitro model system.

Authors:  Waleed Abdel-Aziz; Robert Hickey; Martin Edelman; Linda Malkas
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

8.  Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis.

Authors:  Caroline M Li; Yunan Miao; Robert G Lingeman; Robert J Hickey; Linda H Malkas
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.